School of Medicine
Showing 561-570 of 960 Results
-
Mark Mercola
Professor of Medicine (Cardiovascular) and, by courtesy, of Chemical and Systems Biology
BioDr. Mercola is Professor of Medicine and Professor in the Stanford Cardiovascular Institute. He completed postdoctoral training at the Dana-Farber Cancer Institute and Harvard Medical School, was on the faculty in the Department of Cell Biology at Harvard Medical School for 12 years, and later at the Sanford-Burnham-Prebys Institute and Department of Bioengineering at the University of California, San Diego before relocating to Stanford in 2015.
Prof. Mercola is known for identifying many of the factors that are responsible for inducing and forming the heart, including the discovery that Wnt inhibition is a critical step in cardiogenesis that provided the conceptual basis and reagents for the large-scale production of cardiovascular tissues from pluripotent stem cells. He has collaborated with medicinal chemists, optical engineers and software developers to pioneer the use of patient iPSC-cardiomyocytes for disease modeling, safety pharmacology and drug development. His academic research is focused on developing and using quantitative high throughput assays of patient-specific cardiomyocyte function to discover druggable targets for preserving contractile function in heart failure and promoting regeneration following ischemic injury. He co-established drug screening and assay development at the Conrad Prebys Drug Discovery Center (San Diego), which operated as one of 4 large screening centers of the US National Institutes of Health (NIH) Molecular Libraries screening initiative and continues as one of the largest academic drug screening centers.
Prof. Mercola received an NIH MERIT award for his work on heart formation. He holds numerous patents, including describing the invention of the first engineered dominant negative protein and small molecules for stem cell and cancer applications. He serves on multiple editorial and advisory boards, including Vala Sciences, Regencor, The Ted Rogers Centre for Heart Research and the Human Biomolecular Research Institute. His laboratory is funded by the National Institutes of Health (NIH), California Institute for Regenerative Medicine, Phospholamban Foundation and Fondation Leducq. -
Thomas Charles Merigan M.D.
George E. and Lucy Becker Professor of Medicine, Emeritus
Current Research and Scholarly InterestsI am now emeritus and only participate in university activities through advising my former trainees who have joined the faculty.
-
Sylvia Bereknyei Merrell
Causal temp, Pediatrics - General Pediatrics
Current Role at StanfordResearcher teaching about qualitative research in General Pediatrics. Co-Director of the Medical Education Scholarly Concentration program for the School of Medicine.
-
Matthew Mesias
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioMatthew Mesias, M.D., is a Geriatrician and Clinical Associate Professor of Medicine at Stanford University School of Medicine. He completed his medical degree at Johns Hopkins University School of Medicine and furthered his training internal medicine residency and geriatrics fellowship at the University of Washington. He serves as the Medical Director of the Inpatient Geriatrics Consult Service at Stanford University Hospital. His academic interests include quality improvement in geriatric care, mentorship of medical trainees, and the development of curricula for geriatrics medical education. In 2023, he was awarded the HRSA Geriatric Academic Career Award, which supports his leadership and professional development while creating geriatric educational programs for community-partnered clinics.
